Aaron T. Alpar

783 total citations
18 papers, 454 citations indexed

About

Aaron T. Alpar is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Aaron T. Alpar has authored 18 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Aaron T. Alpar's work include Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (3 papers). Aaron T. Alpar is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (3 papers). Aaron T. Alpar collaborates with scholars based in United States, United Kingdom and Japan. Aaron T. Alpar's co-authors include Jeffrey A. Hubbell, Aslan Mansurov, Melody A. Swartz, Jun Ishihara, Laura Gray, Peyman Hosseinchi, Ako Ishihara, John‐Michael Williford, Michal M. Raczy and Tiffany M. Marchell and has published in prestigious journals such as Scientific Reports, Biophysical Journal and Science Advances.

In The Last Decade

Aaron T. Alpar

17 papers receiving 449 citations

Peers

Aaron T. Alpar

IMMUN

ONCOL

RNMI

Shiyao Du China

Wanhua Yang China

Chad A. Komar United States

Cassandra E. Burnett United States

Nader El-Sayes Canada

Chunbo Dong China

Erminia Romano Belgium

Ruihao Huang China

Maria Stella Sasso United States

Khue G. Nguyen United States

Shiyao Du China

Aaron T. Alpar

218 ×0.9

IMMUN

221 ×1.2

ONCOL

131 ×0.8

65 ×0.8

42 ×0.8

RNMI

Citations per year, relative to Aaron T. Alpar Aaron T. Alpar (= 1×) peers Shiyao Du

Countries citing papers authored by Aaron T. Alpar

Since Specialization

Citations

This map shows the geographic impact of Aaron T. Alpar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron T. Alpar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron T. Alpar more than expected).

Fields of papers citing papers by Aaron T. Alpar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron T. Alpar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron T. Alpar. The network helps show where Aaron T. Alpar may publish in the future.

Co-authorship network of co-authors of Aaron T. Alpar

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron T. Alpar. A scholar is included among the top collaborators of Aaron T. Alpar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron T. Alpar. Aaron T. Alpar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

White, Michael, Michal M. Raczy, Erica Budina, et al.. (2025). Engineering IL-10 and rapamycin to bind collagen leads to improved anti fibrotic efficacy in lung and kidney fibrosis. Scientific Reports. 15(1). 13279–13279. 2 indexed citations

Alpar, Aaron T., et al.. (2025). Thermoreversibly assembled polymersomes for highly efficient loading, processing and delivery of protein and siRNA biologics. Nature Biomedical Engineering. 10(3). 427–444.

Chang, Kevin, Aaron T. Alpar, Ani Solanki, et al.. (2024). Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Advances. 8(7). 1747–1759. 2 indexed citations

White, Michael, Michal M. Raczy, Ani Solanki, et al.. (2024). Blocking antibodies against integrin-α3, -αM, and -αMβ2 de-differentiate myofibroblasts, and improve lung fibrosis and kidney fibrosis. Scientific Reports. 14(1). 21623–21623. 1 indexed citations

Cao, Shijie, Erica Budina, Michal M. Raczy, et al.. (2024). A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice. Nature Biomedical Engineering. 8(5). 611–627. 34 indexed citations

Alpar, Aaron T., Ako Ishihara, Aslan Mansurov, et al.. (2023). Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds. npj Regenerative Medicine. 8(1). 49–49. 6 indexed citations

Mansurov, Aslan, Lisa R. Volpatti, Kevin Chang, et al.. (2023). Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Science Advances. 9(48). eadh9879–eadh9879. 17 indexed citations

Raczy, Michal M., Aaron T. Alpar, Ani Solanki, et al.. (2023). Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics. Cell Reports Medicine. 5(1). 101345–101345. 8 indexed citations

Hauert, Sylvie, Kevin Chang, Aaron T. Alpar, et al.. (2023). Membrane-localized neoantigens predict the efficacy of cancer immunotherapy. Cell Reports Medicine. 4(8). 101145–101145. 4 indexed citations

10.

Mansurov, Aslan, Peyman Hosseinchi, Kevin Chang, et al.. (2022). Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nature Biomedical Engineering. 6(7). 819–829. 63 indexed citations

11.

Mansurov, Aslan, Michal M. Raczy, Kevin Chang, et al.. (2022). Tumor Cell-Surface Binding of Immune Stimulating Polymeric Glyco-Adjuvant via Cysteine-Reactive Pyridyl Disulfide Promotes Antitumor Immunity. ACS Central Science. 8(10). 1435–1446. 18 indexed citations

12.

Mansurov, Aslan, et al.. (2021). Immunoengineering approaches for cytokine therapy. American Journal of Physiology-Cell Physiology. 321(2). C369–C383. 20 indexed citations

13.

Ishihara, Ako, Jun Ishihara, Elyse A. Watkins, et al.. (2020). Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature Biomedical Engineering. 5(5). 387–398. 31 indexed citations

14.

Mansurov, Aslan, Jun Ishihara, Peyman Hosseinchi, et al.. (2020). Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nature Biomedical Engineering. 4(5). 531–543. 178 indexed citations

15.

Ishihara, Ako, Jun Ishihara, Elyse A. Watkins, et al.. (2020). Publisher Correction: Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature Biomedical Engineering. 4(11). 1117–1117. 2 indexed citations

16.

Briquez, Priscilla S., Sylvie Hauert, Alexandre de Titta, et al.. (2020). Engineering Targeting Materials for Therapeutic Cancer Vaccines. Frontiers in Bioengineering and Biotechnology. 8. 19–19. 23 indexed citations

17.

Yuba, Eiji, Erica Budina, Kiyomitsu Katsumata, et al.. (2020). Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin‐10 in Murine Models. Arthritis & Rheumatology. 73(5). 769–778. 26 indexed citations

18.

Busch, David J., et al.. (2018). Entropic Control of Receptor Recycling Using Engineered Ligands. Biophysical Journal. 114(6). 1377–1388. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact